Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Cancer Immunotherapy Market Worth $119.39 Billion by 2021 - Rising Healthcare Expenditure Driving Growth - Research and Markets

Research and Markets
Posted on: 27 Sep 16

Research and Markets has announced the addition of the "Cancer Immunotherapy Market - Global Forecast to 2021" report to their offering.

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries are driving growth in the caner immunotherapy market. However, stringent regulatory policies and side effects associated with cancer therapy are the major factors restraining the growth of this market.

The global cancer immunotherapy market has been segmented on the basis of type, application, end user, and region. The monoclonal antibodies segment is expected to register the highest growth rate in the cancer immunotherapy market, by type, during the forecast period. Factors such as high success rate and less recovery time are contributing to the high growth in this segment.

Geographically, the cancer immunotherapy market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of North America can be attributed to the growing aging population and the increased funding from government and non-government agencies in order to increase the research capacity.

Target Audience for this Report:

  • Drug Manufacturers and Suppliers
  • Academic Research Institutes
  • Hospitals and Clinics
  • Research and Development (R&D) Companies
  • Business Research and Consulting Service Providers
  • Medical Research Laboratories
  • Academic Medical Centers and Universities

Companies Mentioned:

  • Amgen Inc.
  • AstraZeneca
  • Bayer AG
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-LA Roche Ltd.
  • Janssen Global Services LLC (Johnson & Johnson)
  • Merck
  • Novartis
  • Pfizer

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Trends

7 Cancer Immunotherapy Market, By Product Type

8 Cancer Immunotherapy Market, By Application

9 Cancer Immunotherapy Market, By End User

10 Cancer Immunotherapy Market, By Region

11 Competitive Landscape

12 Company Profile

For more information about this report visit

View source version on

Business Wire

Last updated on: 27/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.